3646 results for «525»

Filter By

3646 results

CTO, modern challenges and solutions

21 May 2025 – From EuroPCR 2025

Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.

CTO, modern challenges and solutions

New evidence in the PFO closure

21 May 2025 – From EuroPCR 2025

Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.

New evidence in the PFO closure

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

The many faces of TTVR

21 May 2025 – From EuroPCR 2025

Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.

The many faces of TTVR

Apply now for a chance of granting towards participation at EuroPCR 2026

A limited number of Indirect Industry Supported Grants are available for healthcare practitioners who meet our Industry Partners’ selection criteria
Indirect Industry Supported Grants for EuroPCR 2025

BIOVASC: Immediate complete revascularization as safe and effective as staged procedure in treating multi-vessel disease

05 Mar 2023

Ali Nazmi Calik & Elad Asher summarize the results of the clinical trial presented by Roberto Diletti at the American College of Cardiology Scientific Session (ACC.23/WCC).

Elad Asher

Author

Elad Asher
Ali Nazmi Calik

Author

Ali Nazmi Calik
BIOVASC: Complete revascularization strategies in patients presenting with acute coronary syndromes and multivessel coronary disease
Didn’t find what you were looking for?